On how CCN6 suppresses breast cancer growth and invasion

Journal of Cell Communication and Signaling

Volumn 6, Issue 1, 2012, Pages 5-10

  Huang, Wei ^a   Pal, Anupama ^a   Kleer, Celina G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; CCN6; Epithelial to mesenchymal transition; Inflammatory breast cancer; Insulin like growth factor; WISP3

Indexed keywords

CCN PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN CCN6; SOMATOMEDIN C; UNCLASSIFIED DRUG; UVOMORULIN;

ANOIKIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84863085243     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-011-0148-9     Document Type: Article

References (43)

1. Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M et al (2007) The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 26:6979-6988 (Pubitemid 350014612)
2. Allen NE, Roddam AW, Allen DS, Fentiman IS, Dos Santos SI, Peto J et al (2005) A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. Br J Cancer 92:1283-1287 (Pubitemid 40604405)
3. Benini S, Perbal B, Zambelli D, Colombo MP, Manara MC, Serra M et al (2005) In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene 24:4349-4361 (Pubitemid 40961758)
4. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF et al (2008) A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 68:7846-7854
5. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S et al (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9:582-589 (Pubitemid 351772923)
6. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 60:3744-3748 (Pubitemid 32204562)
7. Carboni JM, Lee AV, Hadsell DL, Rowley BR, Lee FY, Bol DK et al (2005) Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor. Cancer Res 65:3781-3787 (Pubitemid 40616356)
8. Chappell SA, Walsh T, Walker RA, Shaw JA (1997) Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas. Br J Cancer 75:1324-1329 (Pubitemid 27179823)
9. Dawood S, Cristofanilli M (2007) What progress have we made in managing inflammatory breast cancer? Oncology (Williston Park) 21:673-679, discussion 679-680, 686-677 (Pubitemid 46870370)
10. Diorio C, Pollak M, Byrne C, Masse B, Hebert-Croteau N, Yaffe M et al (2005) Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 14:1065-1073 (Pubitemid 40656449)
11. Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, Peeper DS (2004) Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430:1034-1039
12. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M et al (2005) DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24:2375-2385 (Pubitemid 40546696)
13. Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, Hankinson SE (2007) Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev 16:161-164 (Pubitemid 46174280)
14. Fujii H, Zhou W, Gabrielson E (1996) Detection of frequent allelic loss of 6q23-q25.2 in microdissected human breast cancer tissues. Genes Chromosomes Cancer 16:35-39 (Pubitemid 26141252)
15. Graham TR, Zhau HE, Odero-Marah VA, Osunkoya AO, Kimbro KS, Tighiouart M et al (2008) Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res 68:2479-2488 (Pubitemid 351521824)
16. Grotendorst GR, Duncan MR (2005) Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J 19:729-738 (Pubitemid 40617377)
17. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70 (Pubitemid 30046295)
18. Huang W, Zhang Y, Varambally S, Chinnaiyan AM, Banerjee M, Merajver SD et al (2008) Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1. Am J Pathol 172:893-904 (Pubitemid 351519987)
19. Huang W, Gonzalez ME, Toy KA, Banerjee M, Kleer CG (2010) Blockade of CCN6 (WISP3) activates growth factor-independent survival and resistance to anoikis in human mammary epithelial cells. Cancer Res 70:3340-3350
20. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED et al (2007) Epithelial-mesenchymal and mesenchymal- epithelial transitions in carcinoma progression. J Cell Physiol 213:374-383 (Pubitemid 47509716)
21. Jaiyesimi IA, Buzdar AU, Hortobagyi G (1992) Inflammatory breast cancer: a review. J Clin Oncol 10:1014-1024
22. Kim HJ, Litzenburger BC, Cui X, Delgado DA, Grabiner BC, Lin X et al (2007) Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail. Mol Cell Biol 27:3165-3175 (Pubitemid 46581327)
23. Kleer CG, Zhang Y, Pan Q, van Golen KL, Wu ZF, Livant D et al (2002) WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene 21:3172-3180 (Pubitemid 34552242)
24. Kleer CG, Zhang Y, Pan Q, Merajver SD (2004) WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer. Neoplasia 6:179-185 (Pubitemid 38544606)
25. Korpal M, Lee ES, Hu G, Kang Y (2008) The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283:14910-14914
26. Levine PH, Steinhorn SC, Ries LG, Aron JL (1985) Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. J Natl Cancer Inst 74:291-297 (Pubitemid 15112115)
27. Lorenzatti G, Huang W, Pal A, Cabanillas AM, Kleer CG (2011) CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer. J Cell Sci 124:1752-1758
28. Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ et al (2005) The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8:197-209 (Pubitemid 41317591)
29. Moro L, Arbini AA, Yao JL, di Sant'Agnese PA, Marra E, Greco M (2009) Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2. Cell Death Differ 16:571-583
30. Park SM, Gaur AB, Lengyel E, Peter ME (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22:894-907 (Pubitemid 351482843)
31. Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7:415-428 (Pubitemid 46809165)
32. Pollak MN (2004) Insulin-like growth factors and neoplasia. Novartis Found Symp 262:84-98, discussion 98-107, 265-108
33. Rodriguez C, Causse A, Ursule E, Theillet C (2000) At least five regions of imbalance on 6q in breast tumors, combining losses and gains. Genes Chromosomes Cancer 27:76-84
34. Sachdev D, Hartell JS, Lee AV, Zhang X, Yee D (2004) A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells. J Biol Chem 279:5017-5024 (Pubitemid 38199098)
35. Schernhammer ES, Holly JM, Pollak MN, Hankinson SE (2005) Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:699-704 (Pubitemid 40489217)
36. Schmalhofer O, Brabletz S, Brabletz T (2009) E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28:151-166
37. Shirakihara T, Saitoh M, Miyazono K (2007) Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta. Mol Biol Cell 18:3533-3544 (Pubitemid 47378691)
38. Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, Sultan A et al (2008) The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 68:537-544 (Pubitemid 351380082)
39. Surmacz E (2000) Function of the IGF-I receptor in breast cancer. J Mammary Gland Biol Neoplasia 5:95-105
40. Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA, Gumbs AA et al (1997) Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res 57:3079-3083 (Pubitemid 27351714)
41. van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H et al (1999) A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res 5:2511-2519 (Pubitemid 29437336)
42. Ventura AC, Merajver SD (2008) Genetic determinants of aggressive breast cancer. Annu Rev Med 59:199-212 (Pubitemid 351287933)
43. Zhang Y, Pan Q, Zhong H, Merajver SD, Kleer CG (2005) Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells. Breast Cancer Research 7: R1080-R1089